Skip to main content

$4.40 0.06 (1.38%)

High

$4.46

Low

$4.23

Trades

1,020

Turnover

$2,463,536

Volume

565,229
30 June 2023 at 4:10pm
Register to track MYX and receive email alerts.
Subject
MYX Ann: Update - Notification of buy-back - MYX

MYX Ann: Update - Notification of buy-back - MYX

MYX Ann: Update on sale of US retail generics portfolio

MYX Ann: Change of Director's Interest Notice

MYX Ann: Notification of buy-back - MYX

MYX Ann: Change of Director's Interest Notice

MYX Ann: Change of Director's Interest Notice

MYX Ann: Update on convertible note arrangements with Rubric Capital

MYX Ann: Change in substantial holding

MYX Ann: Becoming a substantial holder

MYX Ann: Return of Capital - MYX (cancellation)

MYX Ann: Mayne Pharma announces cancellation of capital return

MYX Ann: 2023 Half Year Investor Presentation

MYX Ann: 2022 Half Year Media Release

MYX Ann: Half Yearly Report and Accounts

MYX Ann: Mayne Pharma announces sale of US retail generics business

MYX Ann: Trading Halt

MYX Ann: Pause in Trading

MYX Ann: MYX signs license & supply agreement for generic Oracea

MYX Ann: MYX announces US launch of Diltiazem ER and Doryx MPC 60mg

MYX Ann: Mayne Pharma to restate US dermatology net revenue for FY22

MYX Ann: Notification of cessation of securities - MYX

MYX Ann: Update - Notification of buy-back - MYX

MYX Ann: US launch of HALOETTE, a generic version of NUVARING

MYX Ann: Return of Capital - MYX (updated)

MYX Ann: JP Morgan Healthcare Conference Presentation

MYX Ann: Mayne Pharma provides update on capital management timeline

MYX Ann: Notification of buy-back - MYX

MYX Ann: Notification regarding unquoted securities - MYX

MYX Ann: MYX completes TherapeuticsMD product licensing transaction

MYX Ann: Section 708A cleansing notice

MYX Ann: Notification of cessation of securities - MYX

MYX Ann: Proposed issue of securities - MYX

MYX Ann: MYX signs license agreement for women's health products

MYX Ann: Results of Meeting

MYX Ann: Chairman's Address to Shareholders

MYX Ann: AGM presentation and business and trading update

MYX Ann: Return of Capital - MYX

MYX Ann: Dividend/Distribution - MYX

MYX Ann: Consolidation/Split - MYX

MYX Ann: 2022 AGM Notice of meeting and shareholder pack

MYX Ann: Mayne Pharma capital management update

MYX Ann: Notification of cessation of securities - MYX

MYX Ann: Annual Report to shareholders

MYX Ann: 2022 Corporate Governance Statement and Appendix 4G

MYX Ann: Mayne Pharma completes sale of Metrics Contract Services

MYX Ann: Initial Director's Interest Notice

MYX Ann: Final Director's Interest Notice x2

MYX Ann: Mayne Pharma appoints new CEO

MYX Ann: Notification regarding unquoted securities - MYX

Register to track MYX and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
NEU
PBP
RCE
SPL